1-13 of 13
Kai Rejeski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The CAR-HEMATOTOX: ready for prime time

Open Access
Jan H. Frenking, Kai Rejeski
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5638–5640.
https://doi.org/10.1182/bloodadvances.2025017509
Published: 2025
Journal Articles

Prognostic Value of Inflammation-Based Scores in R/R LBCL Patients Treated with CD3xCD20 Bispecific T-Cell Engagers

Open Access
Giulia Magno, Kai Rejeski, Giulia Rappa, Sophia Stock, Alessandra Holzem, Maria Landwehr, Maximilian Seib, Nadine Kutsch, Jamila Mammadova, Stephanie Mayer, Shlomzion Aumann, Jonas Van Ham, Shimrit Ringelstein-Harlev, Giuliano Filippini Velazquez, Rebecca Wurm-Kuczera, Julia Katharina Scholz, Uri Greenbaum, Sandeep S Raj, Roni Shouval, Fabian Müller, Bjoern Chapuy, Christoph Schmid, Ofrat Beyar-Katz, Vibeke KJ Vergote, Hendrik Poeck, Ning Dong, Udo Holtick, Ron Ram, Thomas Pabst, Evgenii Shumilov, Georg Lenz, Gloria Iacoboni, Pere Barba, Veit L. Bücklein, Marion Subklewe
Journal: Blood Advances
Blood Adv bloodadvances.2025017766.
https://doi.org/10.1182/bloodadvances.2025017766
Published: 2025
Includes: Supplemental data
Journal Articles

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia

Open Access
Yannis K. Valtis, Chenyu Lin, David Nemirovsky, Sean M. Devlin, Kai Rejeski, Kevin J. Curran, Xiuyan Wang, Nirali N. Shah, Nikeshan Jeyakumar, Katharine Miller, Amy Zhang, Vamsi K. Kota, Ali Al Darobi, Ibrahim N. Muhsen, Joshua P Sasine, Ibrahim Aldoss, Anjali S Advani, Ran Reshef, Evan C. Chen, Noam E. Kopmar, Stephanie B. Tsai, Talal Hilal, Bijal D Shah, Rawan G. Faramand, Melhem M. Solh, Virginia Tan, Evandro D Bezerra, Minoo Battiwalla, Aravind Ramakrishnan, John Mathews, Paul J Shaughnessy, Luke Mountjoy, Rasmus T. Hoeg, Kaitlyn C. Dykes, Aaron C Logan, Muthu Kumaran, Marc S. Schwartz, Sean I Tracy, Jozal Moore, Silvina Odstrcil Bobillo, Noelle V Frey, Matthew P Connor, Abdullah Ladha, Bhagirathbhai Dholaria, Katherine C. Sutherland, Gregory W. Roloff, Lori S. Muffly, Jae H Park
Journal: Blood Advances
Blood Adv bloodadvances.2025017526.
https://doi.org/10.1182/bloodadvances.2025017526
Published: 2025
Includes: Supplemental data
Journal Articles

Immunoglobulin prophylaxis should be initiated after bispecific antibody therapy in multiple myeloma, regardless of IgG levels

Open Access
Rahul Banerjee, Meera Mohan, Kai Rejeski, Benjamin R. Puliafito, Diana D. Cirstea, Gurbakhash Kaur, Shonali Midha, Georgia J. McCaughan, Nikhil M. Kumar, Nikita Mehra, Bhausaheb Bagal, Noopur S. Raje
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4720–4726.
https://doi.org/10.1182/bloodadvances.2025016490
Published: 2025
Journal Articles

Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma

Open Access
Jan H. Frenking, Xiang Zhou, Kai Rejeski, Vivien Wagner, Patrick Costello, Thomas Hielscher, Lilan Gatti, Joseph Kauer, Omar Nadeem, Elias K. Mai, Christian S. Michel, Mirco J. Friedrich, David Sedloev, Niels Weinhold, Hartmut Goldschmidt, Klaus Herfarth, Anita Schmitt, Michael Hundemer, Michael Schmitt, Carsten Müller-Tidow, Max Topp, Hermann Einsele, Peter Dreger, Nikhil C. Munshi, Adam S. Sperling, Leo Rasche, Sandra Sauer, Marc S. Raab
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4151–4166.
https://doi.org/10.1182/bloodadvances.2024015732
Published: 2025
Includes: Supplemental data
Journal Articles

Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes

Free
Yannis K. Valtis, Sean Devlin, Roni Shouval, Kai Rejeski, Magdalena Corona, Alejandro Luna De Abia, Alfredo Rivas-Delgado, Efrat Luttwak, Giulio Cassanello, Ivan Landego, Heiko Schöder, Akshay Bedmutha, Alexander Boardman, Gunjan L. Shah, Michael Scordo, Miguel-Angel Perales, Gilles Salles, M. Lia Palomba, Urvi A. Shah, Jae H. Park
Journal: Blood Advances
Blood Adv (2024) 9 (1): 151–161.
https://doi.org/10.1182/bloodadvances.2024014555
Published: 2024
Includes: Supplemental data
Journal Articles

Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality

Free
Kai Rejeski, Yucai Wang, Doris K. Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Bethge, Javier Munoz, Razan Mohty, Veit L. Bücklein, Pere Barba, Frederick L. Locke, Yi Lin, Michael D. Jain, Marion Subklewe
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1857–1868.
https://doi.org/10.1182/bloodadvances.2023011767
Published: 2024
Includes: Supplemental data
Journal Articles

Navigating the prognostic role of transfusions after CAR-T

Free
Mohammad Alhomoud, Kai Rejeski
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1570–1572.
https://doi.org/10.1182/bloodadvances.2024012583
Published: 2024
Journal Articles

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

Free
Viktoria Blumenberg, Galina Busch, Stephan Baumann, Regina Jitschin, Gloria Iacoboni, Laura Gallur, Josu Iraola-Truchuelo, Eva Hoster, Michael Winkelmann, Konstantin Hellwig, Christian Schmidt, Lisa Frölich, Benjamin Tast, Friederike Hildebrand, Kai Rejeski, Franziska Dekorsy, Christian Schmidkonz, Tobias Bäuerle, Wolfgang G. Kunz, Dimitrios Mougiakakos, Fabian Müller, Michael von Bergwelt-Baildon, Pere Barba, Veit L. Bücklein, Andreas Mackensen, Simon Völkl, Marion Subklewe
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6844–6849.
https://doi.org/10.1182/bloodadvances.2023010364
Published: 2023
Includes: Supplemental data
Journal Articles

Real-world results of CAR T-cell therapy for large B-cell lymphoma with CNS involvement: a GLA/DRST study

Free
Clinical Trials & Observations
Francis Ayuk, Nico Gagelmann, Bastian von Tresckow, Gerald Wulf, Kai Rejeski, Matthias Stelljes, Olaf Penack, Claudia D. Baldus, Nicolaus Kröger, Wolfgang Bethge, Peter Dreger
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5316–5319.
https://doi.org/10.1182/bloodadvances.2023010336
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

Free
Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt-Baildon, Emmanuel Bachy, Pere Barba, Marion Subklewe
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4719–4725.
https://doi.org/10.1182/bloodadvances.2022007776
Published: 2022
Includes: Supplemental data
Journal Articles

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Free
Gloria Iacoboni, Kai Rejeski, Guillermo Villacampa, Jaap A. van Doesum, Annalisa Chiappella, Francesca Bonifazi, Lucia Lopez-Corral, Michiel van Aalderen, Mi Kwon, Nuria Martínez-Cibrian, Stefania Bramanti, Juan Luis Reguera-Ortega, Lina Camacho-Arteaga, Christian Schmidt, Ana Marín-Niebla, Marie José Kersten, Alejandro Martin Garcia-Sancho, Pier Luigi Zinzani, Paolo Corradini, Tom van Meerten, Marion Subklewe, Pere Barba
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3606–3610.
https://doi.org/10.1182/bloodadvances.2021006922
Published: 2022
Includes: Supplemental data
Journal Articles

Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment

Free
Clinical Trials & Observations
Florian Schoeberl, Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, Vanessa Granja Burbano, Veit L. Bücklein, Kai Rejeski, Christian Schmidt, Galina Busch, Michael von Bergwelt-Baildon, Jörg-Christian Tonn, Michael Schmitt, Marion Subklewe, Louisa von Baumgarten
Journal: Blood Advances
Blood Adv (2022) 6 (10): 3022–3026.
https://doi.org/10.1182/bloodadvances.2021006144
Published: 2022